XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.
Z
Z

Zimmer

Texnik xulosa

IndikatorQiymatTrend
IndikatorQiymatTrend
IndikatorQiymatTrend
IndikatorS3S2S1PR1R2R3

Yangiliklar

Australia's Osteopore surges on exclusive distribution agreement

BUZZ-Australia's Osteopore surges on exclusive distribution agreement ** Shares of medical technology firm Osteopore OSX.AX rise as much as 35.7% to A$0.076 ** Stock hits highest level, and posts its biggest intraday pct gain since June 6 ** Co says it signed an exclusive distribution agreement with a unit of Singapore-based Zimmer Biomet ZBH.N **
Z

Zimmer Biomet Holdings On June 28, Got Into A New Five-Year Revolving Credit Agreement & New 364-Day Revolving Credit Agreement

BRIEF-Zimmer Biomet Holdings On June 28, Got Into A New Five-Year Revolving Credit Agreement & New 364-Day Revolving Credit Agreement July 1 (Reuters) - Zimmer Biomet Holdings Inc ZBH.N : ZIMMER BIOMET HOLDINGS: ON JUNE 28, GOT INTO A NEW FIVE-YEAR REVOLVING CREDIT AGREEMENT & NEW 364-DAY REVOLVING CREDIT AGREEMENT ZIMMER BIOMET HOLDINGS INC: FIVE-
Z

U.S. AT&T, ATI, California Resources

U.S. RESEARCH ROUNDUP-AT&T, ATI, California Resources July 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AT&T, ATI and California Resources, on Monday. HIGHLIGHTS * AT&T Inc T.N : JP Morgan adds stock to its U.S. analyst focus list * ATI Inc ATI.N : JP Morgan removes stock from its U.S.
A
I
N
W
H
Z
T
U

RevelAi Health And Zimmer Biomet Announce Exclusive Multi-Year Co-Marketing Agreement To Advance Value-Based Care And Health Equity Through Powered Technology

BRIEF-RevelAi Health And Zimmer Biomet Announce Exclusive Multi-Year Co-Marketing Agreement To Advance Value-Based Care And Health Equity Through AI-Powered Technology June 12 (Reuters) - Zimmer Biomet Holdings Inc ZBH.N : REVELAI HEALTH AND ZIMMER BIOMET ANNOUNCE EXCLUSIVE MULTI-YEAR CO-MARKETING AGREEMENT TO ADVANCE VALUE-BASED CARE AND HEALTH EQ
Z

Zimmer Biomet Holdings Inc Sees Mid-Single-Digit Percentage Constant Currency Consolidated Revenue Compound Annual Growth Rate For 2024 Through 2027

BRIEF-Zimmer Biomet Holdings Inc Sees Mid-Single-Digit Percentage Constant Currency Consolidated Revenue Compound Annual Growth Rate For 2024 Through 2027 Zimmer Biomet Holdings Inc ZBH.N : ZIMMER BIOMET HOLDINGS INC: SEES MID-SINGLE-DIGIT PERCENTAGE CONSTANT CURRENCY CONSOLIDATED REVENUE COMPOUND ANNUAL GROWTH RATE FOR 2024 THROUGH 2027 ZIMMER BIO
Z

Shartlar

Ommabop aktivlar

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.